eISSN: 1732-2707
ISSN: 1730-1270
HIV & AIDS Review. International Journal of HIV-Related Problems
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2016
vol. 15
 
Share:
Share:
abstract:
Original paper

Preparation and characterization of Efavirenz nanosuspension with the application of enhanced solubility and dissolution rate

Pavan Kommavarapu
,
Arthanareeswari Maruthapillai
,
Kamaraj Palanisamy

HIV & AIDS Review Volume 15, Issue 4, 2016, Pages 170–176
Online publish date: 2017/01/11
View full text Get citation
 
Aim

Intend of the present exertion is to prepare β-cyclodextrin (β-CD) based polymeric nanosuspension (PNS) of Efavirenz (EFV) with enhanced aqueous solubility and dissolution rate as compared to pure drug.



Background

EFV is a low aqueous soluble molecule because of which there is drug absorption problem. To overcome this problem polymeric nanosuspension were prepared using precipitation method which produced successful results.



Materials and methods

Four formulations (β-CDPNS1, β-CDPNS2, β-CDPNS3 and β-CDPNS4) with varying drug-polymer ratios were prepared by precipitating drug-polymer physical mixtures dissolved in organic phase in an aqueous phase. Solid state characterization of β-CDPNS's were conducted using X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy-universal attenuated total reflectance (FTIR-UATR), and scanning electron microscopy (SEM) to examine physical properties and to study the compatibility of EFV with pharmaceutical excipients. Dynamic light scattering (DLS) studies was performed for nanoparticles evaluation.



Results

The mean diameter of the nanoparticles ranged between 143.8 and 284.4 nm and polydispersity index (Pdi) values for all the nanosuspensions were small (<0.30) indicating the uniform mono-disperse with zeta potential (mV) values ranging from −38.3 to −27.5 mV. SEM images revealed the layered morphology for all β-CDPNS. The solubility and dissolution profile of EFV nanosuspensions markedly increased when compared to the original drug. Kinetics of drug release mechanism was studied using eight mathematical models and found that the release profiles of β-CDPNS were best described by Weibull model with dissolution efficiency (DE) >60% in each formulation.



Conclusion

Successful preparation and characterization of Efavirenz nanosuspension by solvent injection method has been accomplished in this study.
keywords:

Efavirenz; Bioavailability; Nanosuspension; Mathematical model; Dissolution efficiency

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.